Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 Mar;78(3):421–429.

Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

T Chardès 1, F Velge-Roussel 1, P Mevelec 1, M N Mevelec 1, D Buzoni-Gatel 1, D Bout 1
PMCID: PMC1421842  PMID: 8478024

Abstract

This study was performed to determine the T-cellular immune responses following Toxoplasma gondii oral infection and to assess further toxoplasma antigens on their ability to stimulate in vitro mucosal and systemic T-cell immunity. Parasite-specific cellular immune responses in Peyer's patches (PP), in mesenteric lymph nodes (MLN) and in spleen (SPL) were investigated using a lymphoblastic transformation test following oral infection of mice with strain 76K cysts of T. gondii. An early toxoplasma sonicate-induced mucosal T-cell proliferation occurred in MLN and PP with a peak responsiveness on day 6 post-infection (PI) and rapidly reached background levels on day 7 PI in PP and on day 8 PI in mesenteric lymph nodes. A later splenic cellular blastogenesis was observed from day 28 PI and persisted throughout the experiment (day 91). At the time of T-cell proliferation, FACS analyses revealed a decrease in the relative percentages of CD4+ and CD8+ T cells with a predominance of CD8+ lymphocytes which leads to an inversion of the CD4/CD8 ratios. We found that CBA/J is a high responder mouse strain in the induction of mesenteric and splenic T-lymphocyte blastogenesis compared to the intermediate responder BALB/c and low responder C57BL/6. Toxoplasma gondii antigens SAG1 (30,000 MW) and GRA4 (40,000-41,000 MW), which are known to induce locally IgA antibodies, are shown to stimulate primed mucosal T lymphocytes from CBA/J and BALB/c mice whereas no proliferation was demonstrated with C57BL/6 T cells. 229-242 peptide, derived from the deduced amino acid sequence of GRA4, only induces detectable proliferation of primed-CBA/J T lymphocytes. Following oral experimental infection, the in vitro mesenteric response to a toxoplasma sonicate is dominated by a Th2-type cytokine pattern whereas a predominant Th1 cytokine response is observed in the spleen. Finally, in vitro stimulation of mesenteric T cells with the three defined toxoplasma antigens resulted in secretion of interleukin-5 (IL-5) and IL-6 (except for SAG1) and interferon-gamma (IFN-gamma) whereas no detectable IL-2 or IL-4 was observed.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achbarou A., Mercereau-Puijalon O., Sadak A., Fortier B., Leriche M. A., Camus D., Dubremetz J. F. Differential targeting of dense granule proteins in the parasitophorous vacuole of Toxoplasma gondii. Parasitology. 1991 Dec;103(Pt 3):321–329. doi: 10.1017/s0031182000059837. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. E., Jr, Krahenbuhl J. L., Remington J. S. Longitudinal studies of lymphocyte response to Toxoplasma antigen in humans infected with T. gondii. J Clin Lab Immunol. 1979 Nov;2(4):293–297. [PubMed] [Google Scholar]
  3. Brinkmann V., Remington J. S., Sharma S. D. Protective immunity in toxoplasmosis: correlation between antibody response, brain cyst formation, T-cell activation, and survival in normal and B-cell-deficient mice bearing the H-2k haplotype. Infect Immun. 1987 Apr;55(4):990–994. doi: 10.1128/iai.55.4.990-994.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burg J. L., Perelman D., Kasper L. H., Ware P. L., Boothroyd J. C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988 Nov 15;141(10):3584–3591. [PubMed] [Google Scholar]
  5. Canessa A., Pistoia V., Roncella S., Merli A., Melioli G., Terragna A., Ferrarini M. An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J Immunol. 1988 May 15;140(10):3580–3588. [PubMed] [Google Scholar]
  6. Chardès T., Bourguin I., Mevelec M. N., Dubremetz J. F., Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun. 1990 May;58(5):1240–1246. doi: 10.1128/iai.58.5.1240-1246.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Couvreur G., Sadak A., Fortier B., Dubremetz J. F. Surface antigens of Toxoplasma gondii. Parasitology. 1988 Aug;97(Pt 1):1–10. doi: 10.1017/s0031182000066695. [DOI] [PubMed] [Google Scholar]
  8. Dialynas D. P., Quan Z. S., Wall K. A., Pierres A., Quintáns J., Loken M. R., Pierres M., Fitch F. W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 1983 Nov;131(5):2445–2451. [PubMed] [Google Scholar]
  9. Dunkley M. L., Husband A. J., Underdown B. J. Cognate T-cell help in the induction of IgA responses in vivo. Immunology. 1990 Sep;71(1):16–19. [PMC free article] [PubMed] [Google Scholar]
  10. Duquesne V., Auriault C., Gras-Masse H., Boutillon C., Darcy F., Cesbron-Delauw M. F., Tartar A., Capron A. Identification of T cell epitopes within a 23-kD antigen (P24) of Toxoplasma gondii. Clin Exp Immunol. 1991 Jun;84(3):527–534. [PMC free article] [PubMed] [Google Scholar]
  11. Else K. J., Grencis R. K. Cellular immune responses to the murine nematode parasite Trichuris muris. I. Differential cytokine production during acute or chronic infection. Immunology. 1991 Apr;72(4):508–513. [PMC free article] [PubMed] [Google Scholar]
  12. Frenkel J. K. Pathophysiology of toxoplasmosis. Parasitol Today. 1988 Oct;4(10):273–278. doi: 10.1016/0169-4758(88)90018-x. [DOI] [PubMed] [Google Scholar]
  13. Gazzinelli R. T., Hakim F. T., Hieny S., Shearer G. M., Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol. 1991 Jan 1;146(1):286–292. [PubMed] [Google Scholar]
  14. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  15. Grencis R. K., Hültner L., Else K. J. Host protective immunity to Trichinella spiralis in mice: activation of Th cell subsets and lymphokine secretion in mice expressing different response phenotypes. Immunology. 1991 Oct;74(2):329–332. [PMC free article] [PubMed] [Google Scholar]
  16. Grencis R. K., Wakelin D. Short lived, dividing cells mediate adoptive transfer of immunity to Trichinella spiralis in mice. I. Availability of cells in primary and secondary infections in relation to cellular changes in the mesenteric lymph node. Immunology. 1982 Jun;46(2):443–450. [PMC free article] [PubMed] [Google Scholar]
  17. Guilloteau L., Buzoni-Gatel D., Blaise F., Bernard F., Pépin M. Phenotypic analysis of splenic lymphocytes and immunohistochemical study of hepatic granulomas after a murine infection with Salmonella abortusovis. Immunology. 1991 Dec;74(4):630–637. [PMC free article] [PubMed] [Google Scholar]
  18. Hakim F. T., Gazzinelli R. T., Denkers E., Hieny S., Shearer G. M., Sher A. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol. 1991 Oct 1;147(7):2310–2316. [PubMed] [Google Scholar]
  19. Hauser W. E., Jr, Tsai V. Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro. J Immunol. 1986 Jan;136(1):313–319. [PubMed] [Google Scholar]
  20. Husband A. J., Dunkley M. L., Cripps A. W., Clancy R. L. Antigen-specific response among T lymphocytes following intestinal administration of alloantigens. Aust J Exp Biol Med Sci. 1984 Dec;62(Pt 6):687–699. doi: 10.1038/icb.1984.65. [DOI] [PubMed] [Google Scholar]
  21. Issekutz T. B. The response of gut-associated T lymphocytes to intestinal viral immunization. J Immunol. 1984 Dec;133(6):2955–2960. [PubMed] [Google Scholar]
  22. Johnson A. M. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis. Z Parasitenkd. 1984;70(3):303–309. doi: 10.1007/BF00927816. [DOI] [PubMed] [Google Scholar]
  23. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  24. Kasper L. H., Crabb J. H., Pfefferkorn E. R. Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. J Immunol. 1983 May;130(5):2407–2412. [PubMed] [Google Scholar]
  25. Laugier M., Quilici M. Intérêt expérimental d'une souche de Toxoplasme peu pathogène pour la souris. Ann Parasitol Hum Comp. 1970 Jul-Aug;45(4):389–403. [PubMed] [Google Scholar]
  26. Lautenslager J. P. Toxoplasmosis as a significant disease in man and animals with special reference to preventive measures by the farm community. Can Vet J. 1987 May;28(5):261–264. [PMC free article] [PubMed] [Google Scholar]
  27. Luft B. J., Kansas G., Engleman E. G., Remington J. S. Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. J Infect Dis. 1984 Nov;150(5):761–767. doi: 10.1093/infdis/150.5.761. [DOI] [PubMed] [Google Scholar]
  28. Luft B. J., Pedrotti P. W., Engleman E. G., Remington J. S. Induction of antigen-specific suppressor T cells during acute infection with Toxoplasma gondii. J Infect Dis. 1987 May;155(5):1033–1037. doi: 10.1093/infdis/155.5.1033. [DOI] [PubMed] [Google Scholar]
  29. Luft B. J., Pedrotti P. W., Remington J. S. In vitro generation of adherent mononuclear suppressor cells to Toxoplasma antigen. Immunology. 1988 Apr;63(4):643–648. [PMC free article] [PubMed] [Google Scholar]
  30. McLeod R., Estes R. G., Mack D. G., Cohen H. Immune response of mice to ingested Toxoplasma gondii: a model of toxoplasma infection acquired by ingestion. J Infect Dis. 1984 Feb;149(2):234–244. doi: 10.1093/infdis/149.2.234. [DOI] [PubMed] [Google Scholar]
  31. McLeod R., Estes R. G. Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans. Clin Exp Immunol. 1985 Oct;62(1):24–30. [PMC free article] [PubMed] [Google Scholar]
  32. Mevelec M. N., Chardès T., Mercereau-Puijalon O., Bourguin I., Achbarou A., Dubremetz J. F., Bout D. Molecular cloning of GRA4, a Toxoplasma gondii dense granule protein, recognized by mucosal IgA antibodies. Mol Biochem Parasitol. 1992 Dec;56(2):227–238. doi: 10.1016/0166-6851(92)90172-g. [DOI] [PubMed] [Google Scholar]
  33. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  34. Parker S. J., Inchley C. J. Heligmosomoides polygyrus: influence of infection on lymphocyte subpopulations in mouse mesenteric lymph nodes. Exp Parasitol. 1990 Oct;71(3):249–258. doi: 10.1016/0014-4894(90)90029-c. [DOI] [PubMed] [Google Scholar]
  35. Pierres M., Goridis C., Golstein P. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol. 1982 Jan;12(1):60–69. doi: 10.1002/eji.1830120112. [DOI] [PubMed] [Google Scholar]
  36. Ramsay A. J., Holmes M. J. A rabbit model for mucosal immunity in the bowel. II. Local cellular reactivity to virus infection. Immunology. 1990 Jan;69(1):27–32. [PMC free article] [PubMed] [Google Scholar]
  37. Roch F., Bach M. A. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells. Clin Immunol Immunopathol. 1991 Sep;60(3):443–454. doi: 10.1016/0090-1229(91)90100-o. [DOI] [PubMed] [Google Scholar]
  38. Saavedra R., Hérion P. Human T-cell clones against Toxoplasma gondii: production of interferon-gamma, interleukin-2, and strain cross-reactivity. Parasitol Res. 1991;77(5):379–385. doi: 10.1007/BF00931632. [DOI] [PubMed] [Google Scholar]
  39. Saavedra R., de Meuter F., Decourt J. L., Hérion P. Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. J Immunol. 1991 Sep 15;147(6):1975–1982. [PubMed] [Google Scholar]
  40. Sharma S. D., Mullenax J., Araujo F. G., Erlich H. A., Remington J. S. Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol. 1983 Aug;131(2):977–983. [PubMed] [Google Scholar]
  41. Sibley L. D., Pfefferkorn E. R., Boothroyd J. C. Proposal for a uniform genetic nomenclature in Toxoplasma gondii. Parasitol Today. 1991 Dec;7(12):327–328. doi: 10.1016/0169-4758(91)90210-f. [DOI] [PubMed] [Google Scholar]
  42. Sklenar I., Jones T. C., Alkan S., Erb P. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis. 1986 Feb;153(2):315–324. doi: 10.1093/infdis/153.2.315. [DOI] [PubMed] [Google Scholar]
  43. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516–518. doi: 10.1126/science.3128869. [DOI] [PubMed] [Google Scholar]
  44. Suzuki Y., Remington J. S. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol. 1988 Jun 1;140(11):3943–3946. [PubMed] [Google Scholar]
  45. Suzuki Y., Remington J. S. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol. 1990 Mar 1;144(5):1954–1956. [PubMed] [Google Scholar]
  46. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P. G., Rubira M. R., Simpson R. J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679–9683. doi: 10.1073/pnas.83.24.9679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vollmer T. L., Waldor M. K., Steinman L., Conley F. K. Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS. J Immunol. 1987 Jun 1;138(11):3737–3741. [PubMed] [Google Scholar]
  48. Wilson A. D., Bailey M., Williams N. A., Stokes C. R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol. 1991 Oct;21(10):2333–2339. doi: 10.1002/eji.1830211007. [DOI] [PubMed] [Google Scholar]
  49. Yano A., Aosai F., Ohta M., Hasekura H., Sugane K., Hayashi S. Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells. J Parasitol. 1989 Jun;75(3):411–416. [PubMed] [Google Scholar]
  50. Yano A., Aosai F., Yamashita K., Sugane K., Hayashi S. Immune response to Toxoplasma gondii--alteration of antigen specificity of peripheral blood leukocyte proliferative responses in acute toxoplasmosis. Microbiol Immunol. 1987;31(4):345–355. doi: 10.1111/j.1348-0421.1987.tb03095.x. [DOI] [PubMed] [Google Scholar]
  51. Yano A., Norose K., Yamashita K., Aosai F., Sugane K., Segawa K., Hayashi S. Immune response to Toxoplasma gondii--analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis. J Parasitol. 1987 Oct;73(5):954–961. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES